The association between symptomatic sensory neuropathy and body stature in diabetic patients

Jay M Sosenko, Andrew J M Boulton, Maria T. Gadia, John D. Ward, Jay S Skyler

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

In the diabetic patient the clinical manifestations of peripheral neuropathy occur more commonly in the distributions of longer neurons. Utilizing height as a proxy variable, we have examined whether neuron length is also a determinant for the occurrence of peripheral neuropathy among diabetic patients. In studies performed at two sites (Sheffield and Miami) the heights of diabetic patients with symptomatic peripheral neuropathy were compared with those of non-neuropathic diabetic patients. At each site the neuropathic patients were significantly taller (P = 0.02 for Sheffield and P = 0.01 for Miami). These data were not biased by age or race. Body stature (as a proxy for neuron length) appears to be a constitutional risk factor for diabetic peripheral neuropathy.

Original languageEnglish
Pages (from-to)95-98
Number of pages4
JournalDiabetes Research and Clinical Practice
Volume4
Issue number2
DOIs
StatePublished - Jan 1 1988

Fingerprint

Peripheral Nervous System Diseases
Proxy
Neurons
Diabetic Neuropathies

Keywords

  • (Diabetes)
  • Body stature
  • Peripheral neuropathy

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

The association between symptomatic sensory neuropathy and body stature in diabetic patients. / Sosenko, Jay M; Boulton, Andrew J M; Gadia, Maria T.; Ward, John D.; Skyler, Jay S.

In: Diabetes Research and Clinical Practice, Vol. 4, No. 2, 01.01.1988, p. 95-98.

Research output: Contribution to journalArticle

@article{b531752b571f403c834159f9c5a20645,
title = "The association between symptomatic sensory neuropathy and body stature in diabetic patients",
abstract = "In the diabetic patient the clinical manifestations of peripheral neuropathy occur more commonly in the distributions of longer neurons. Utilizing height as a proxy variable, we have examined whether neuron length is also a determinant for the occurrence of peripheral neuropathy among diabetic patients. In studies performed at two sites (Sheffield and Miami) the heights of diabetic patients with symptomatic peripheral neuropathy were compared with those of non-neuropathic diabetic patients. At each site the neuropathic patients were significantly taller (P = 0.02 for Sheffield and P = 0.01 for Miami). These data were not biased by age or race. Body stature (as a proxy for neuron length) appears to be a constitutional risk factor for diabetic peripheral neuropathy.",
keywords = "(Diabetes), Body stature, Peripheral neuropathy",
author = "Sosenko, {Jay M} and Boulton, {Andrew J M} and Gadia, {Maria T.} and Ward, {John D.} and Skyler, {Jay S}",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/S0168-8227(88)80003-2",
language = "English",
volume = "4",
pages = "95--98",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - The association between symptomatic sensory neuropathy and body stature in diabetic patients

AU - Sosenko, Jay M

AU - Boulton, Andrew J M

AU - Gadia, Maria T.

AU - Ward, John D.

AU - Skyler, Jay S

PY - 1988/1/1

Y1 - 1988/1/1

N2 - In the diabetic patient the clinical manifestations of peripheral neuropathy occur more commonly in the distributions of longer neurons. Utilizing height as a proxy variable, we have examined whether neuron length is also a determinant for the occurrence of peripheral neuropathy among diabetic patients. In studies performed at two sites (Sheffield and Miami) the heights of diabetic patients with symptomatic peripheral neuropathy were compared with those of non-neuropathic diabetic patients. At each site the neuropathic patients were significantly taller (P = 0.02 for Sheffield and P = 0.01 for Miami). These data were not biased by age or race. Body stature (as a proxy for neuron length) appears to be a constitutional risk factor for diabetic peripheral neuropathy.

AB - In the diabetic patient the clinical manifestations of peripheral neuropathy occur more commonly in the distributions of longer neurons. Utilizing height as a proxy variable, we have examined whether neuron length is also a determinant for the occurrence of peripheral neuropathy among diabetic patients. In studies performed at two sites (Sheffield and Miami) the heights of diabetic patients with symptomatic peripheral neuropathy were compared with those of non-neuropathic diabetic patients. At each site the neuropathic patients were significantly taller (P = 0.02 for Sheffield and P = 0.01 for Miami). These data were not biased by age or race. Body stature (as a proxy for neuron length) appears to be a constitutional risk factor for diabetic peripheral neuropathy.

KW - (Diabetes)

KW - Body stature

KW - Peripheral neuropathy

UR - http://www.scopus.com/inward/record.url?scp=0023551246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023551246&partnerID=8YFLogxK

U2 - 10.1016/S0168-8227(88)80003-2

DO - 10.1016/S0168-8227(88)80003-2

M3 - Article

C2 - 3342735

AN - SCOPUS:0023551246

VL - 4

SP - 95

EP - 98

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 2

ER -